[ad_1]
AstraZenecarena Covid-19 vaccine It is “safe and effective” and should continue to be used by the European Medicines Agency announced today after review concerns about blood clotting.
But the agency said it could not rule out a link to two rare blood clotting conditions in 25 people who were vaccinated. He added that warnings should be included with information about the vaccine given to doctors and patients. Nine of these people have died.
EU Pharmacovigilance Risk Assessment Committee (PRAC) asked for review of AstraZeneca vaccine safety More than 20 European countries – including Germany, France, Italy and Spain – stop vaccinations after reporting rare coagulation disorders.
Following the EMA’s announcement, Germany, France, Italy and Spain said so would start again Using the AstraZeneca vaccine.
On Thursday, EMA Executive Director Emer Cooke said in a press conference that the commission has found a reduction in the overall incidence of blood clots compared to the general population in nearly 20 million people who have been vaccinated worldwide so far.
“The commission has come to a clear scientific conclusion,” he said. “It’s a safe and effective vaccine.”
But PRAC president Sabine Straus said experts could not rule out ruling out a link to 18 so-called disease cases. actual cerebral sinus thrombosis (CVST) and seven cases extended individual coagulation (DIC), both of which have been seen to reduce the number of platelets in the blood. In CVST, clots can prevent blood from flowing out of the brain, causing bleeding. DIC is a condition in which small clots form in the blood vessels throughout the body, which can cause serious damage to organs.
The EMA will continue to investigate these events and possible links to the vaccine. Cook stressed that the benefits of the AstraZeneca vaccine in protecting against COVID-19, which currently kills thousands of Europeans every week, is far greater than the risk of clotting.
“So what the committee has recommended is to raise awareness,” he said.
Some experts speculated that the coagulation events were linked to certain batches of the vaccine, but Straus said the EMA did not support that theory. “PRAC has not demonstrated any quality or link issues,” he said.
The White House on Thursday confirmed reports that the Biden administration will ship 2.5 million doses of the AstraZeneca vaccine to Mexico and 1.5 million to Canada. These shots will be from home supplies awaiting FDA approval, which could come as soon as next month after the completion of a major U.S. vaccine test.
The movement continues dose request From Mexico earlier in the week. Biden told reporters on Thursday that the U.S. is discussing overseas shipments overseas after the domestic vaccine is over. A senior FDA official Peter Marks told Congress on Wednesday that his agency is concerned about exporting too many overdoses if the vaccine’s immunity is proven to be short-lived and if booster shots are needed for the U.S. population.
Others have speculated whether the AstraZeneca vaccine will cause more problems in the U.S. because anti-vaxxers have taken over the ownership problems.
“Does he really have a niche to fill? Would that be enough confidence? Or will it just be another headache? “John Moore, a virologist at Weill Cornell Medical College in New York who works on vaccine development, told BuzzFeed News earlier this week.
[ad_2]
Source link
